Research Tier I
The National MPS Society's Research Tier I grant funds major multidisciplinary research advancing understanding or treatment of MPS and ML.
Funder: National MPS Society
Due Dates: March 13, 2026 (LOI, Cycle I) | May 22, 2026 (Full Proposal, Cycle I) | August 7, 2026 (LOI, Cycle II) | October 2, 2026 (Full Proposal, Cycle II)
Funding Amounts: Up to $100,000 over 1–2 years per award; one competitive renewal allowed (max $200,000 over 4 years).
Summary: Supports complex, high-impact, multidisciplinary research addressing critical questions in mucopolysaccharidosis (MPS) and mucolipidosis (ML).
Key Information: Open to international and U.S. researchers; only one application per lab per cycle; indirect costs and PI salary generally not allowed.
Description
This program funds ambitious, multidisciplinary scientific or clinical research projects that address complex, high-priority questions or unmet needs in mucopolysaccharidosis (MPS) and mucolipidosis (ML). The goal is to catalyze significant advances in the understanding, treatment, or management of these rare lysosomal storage diseases. Research Tier I grants are intended for substantial projects with the potential for high impact, supporting innovative approaches and fostering progress toward better therapies and cures.
